68642 Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices 

Contact Person: Lawrence Ka-Yun Ng, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6152, 

MSC 7804, Bethesda, MD 20892, 301–435– 

1719, ngkl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Member 

Conflict: Vascular Biology and Hematology. 

Date: November 29, 2023. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Courtney Elaine Watkins, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 496–3093, courtney.watkins2@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Member 

Conflict: Hematology and Vascular 

Pathophysiology. 

Date: November 29, 2023. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Ai-Ping Zou, MD, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4118, 

Bethesda, MD 20892, (301) 408–9497, zouai@

csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Fellowships: 

Physiology and Pathobiology of 

Cardiovascular and Respiratory Systems. 

Date: November 30–December 1, 2023. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Kimm Hamann, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4118A, 

MSC 7814, Bethesda, MD 20892, 301–435– 

5575, hamannkj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Member 

Conflict: Topics in Bacterial Virulence and 

Bacterial-Host Interactions. 

Date: November 30, 2023. 

Time: 1:30 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Liying Guo, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4198, 

MSC 7812, Bethesda, MD 20892, (301) 827– 

7728, lguo@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: September 28, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–21888 Filed 10–3–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Tribal Opioid Response (TOR) 

Consultation 

AGENCY: Substance Abuse and Mental 

Health Services Administration 

(SAMHSA), HHS. 

ACTION: Notice of meeting and request 

for testimony. 

SUMMARY: SAMHSA announces a Tribal 

Consultation Session on the Tribal 

Opioid Response (TOR) grant funding 

methodology. SAMHSA will host 

American Indian and Alaska Native 

(AI/AN) Federally Recognized Tribes for 

a virtual Tribal consultation session. 

DATES: The Tribal consultation will be 

held on November 9th, at 2 p.m. ET. 

SAMHSA will accept written Tribal 

testimony until 5 p.m., November 23rd, 

2023. 

ADDRESSES: Written tribal testimony 

should be submitted by email to otap@

samhsa.hhs.gov. All submissions must 

include Tribal affiliation. All relevant 

comments, including any personal 

information provided, will be posted 

without change. 

FOR FURTHER INFORMATION CONTACT: 

Karen Hearod, MSW, LCSW, Director, 

Office of Tribal Affairs and Policy, 

Substance Abuse and Mental Health 

Services Administration, Telephone: 

202–868–9931, Email: otap@

samhsa.hhs.gov. 

SUPPLEMENTARY INFORMATION: Federally 

Recognized Indian Tribes represented 

by the Tribal President, Tribal Chair, or 

Tribal Governor, or an elected or 

appointed Tribal Leader, or their 

authorized representative(s) may 

participate in this consultation by 

submitting written views, opinions, 

recommendations, and data. Testimony 

received, including attachments and 

other supporting materials, are part of 

the public record and subject to public 

disclosure. Do not include any 

information in your testimony or 

supporting materials considered 

confidential or inappropriate for public 

disclosure. If you include your name, 

contact information, or other personal 

identifiers in the body of your 

testimony, that information will be on 

public display. SAMHSA will review all 

submissions and may choose to redact, 

or withhold, submissions containing 

private or proprietary information such 

as Social Security numbers, medical 

information, inappropriate language, or 

duplicate/near duplicate examples of a 

mass-mail campaign. SAMHSA will 

carefully consider all testimony 

submitted into the docket. 

Oral Tribal Testimony: Based on the 

number of participants giving testimony 

and the time available, it may be 

necessary to limit speaking times for 

each presenter. We will adjourn the 

Tribal consultation meeting early if all 

attendees who requested to provide oral 

testimony in advance of and during the 

consultation have delivered their 

testimony. 

Written Tribal Testimony: Written 

testimony will be accepted per the 

instructions provided in the ADDRESSES

section above. Written testimony 

received in advance of the meeting will 

be included in the official record of the 

meeting. The consultation meeting will 

be recorded, transcribed, and posted 

without change to https://

www.samhsa.gov/tribal-affairs/newsevents, including any personal 

information provided. 

This meeting is being held in 

accordance with Presidential Executive 

Order No. 13175, November 6, 2000, 

and Presidential Memorandums of 

November 5, 2009, and September 23, 

2004, and January 26, 2021 on 

Consultation and Coordination with 

Indian Tribal Government and 

SAMHSA’s Tribal Consultation Policy, 

which can be found at: https://

www.samhsa.gov/sites/default/files/ 

topics/tribal_affairs/tribal-consultationpolicy-2017.pdf. 

Purpose: The purpose of this 

Consultation meeting is to advance 

SAMHSA support for, and collaboration 

with, federally recognized American 

Indian and Alaska Native (AI/AN) 

Tribes. To advance these goals, 

SAMHSA conducts government-togovernment consultations with Indian 

Tribes represented by the Tribal 

President, Tribal Chair, or Tribal 

Governor, or an elected or appointed 

Tribal Leader, or their authorized 

representative(s) to the extent 

practicable and permitted by law before 

SAMHSA takes any action that will 

significantly affect Indian Tribes. 

Consultation is an enhanced form of 

communication that emphasizes trust, 

respect, and shared responsibility. It is 

an open and free exchange of 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices 68643 

information and opinion among parties 

that leads to mutual understanding. 

Matters To Be Considered: 

The Tribal Opioid Response Program 

was first authorized in 2018 along with 

the State Opioid Response Program 

(SOR) under Title II Division H of the 

Consolidated Appropriations Act, 2018. 

This announcement addressed Healthy 

People 2020, Substance Abuse Topic 

Area HP 2020–SA. All grants and subawards made under this announcement 

were governed by 45 CFR part 75. 

The purpose of the TOR program is to 

assist in addressing the overdose crisis 

in Tribal communities by increasing 

access to treatment of opioid use 

disorder (MOUD), and supporting the 

continuum of prevention, harm 

reduction, treatment, and recovery 

support services for opioid use disorder 

(OUD) and co-occurring substance use 

disorders. 

The TOR program also supports the 

full continuum of prevention, harm 

reduction, treatment and recovery 

support services for stimulant misuse 

and use disorders, including for cocaine 

and methamphetamine. The TOR 

program emphasizes the use of 

medication-assisted treatment using one 

of the three FDA-approved medications 

for OUDs. 

The TOR program encourages the use 

of traditional practices. Funding is for a 

two-year time frame. Since inception 

the TOR program has been funded using 

the user population estimates 

distributed by the Indian Health 

Services (IHS). SAMHSA is interested in 

receiving feedback and suggestions for 

alternate funding methodologies for the 

TOR program, including the questions 

below. 

Should SAMHSA continue to use the 

IHS user population estimates as the 

basis for determining TOR grant award 

amounts? If so, what tiers of funding 

should be established? 

Should SAMHSA award each TOR 

grant recipient the same amount, similar 

to other SAMHSA discretionary Tribal 

grant programs? 

Should SAMHSA award funds based 

on proposed number of clients served 

using grant funding? 

Should SAMHSA award funds based 

on proposed activities that will be 

funded through the grant? 

Should SAMHSA use some 

combination of the above 

methodologies? 

What other methodologies should be 

considered instead? 

Meeting Information: Zoom Virtual 

Tribal Consultation. If you wish to 

attend the virtual consultation session, 

please register here: https://

www.zoomgov.com/meeting/register/

vJItdu6qpzsoH6xCvLz

SWzOWOK3ENOV2iWQ. 

Instructions to access the Zoom 

virtual consultation will be provided in 

the link following registration. All 

elected Tribal officials are encouraged to 

submit written Tribal testimony by 

email. 

Dated: September 28, 2023. 

Carlos Castillo, 

Committee Management Officer. 

[FR Doc. 2023–21967 Filed 10–3–23; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HOMELAND 

SECURITY 

[Docket ID FEMA–2014–0022] 

Technical Mapping Advisory Council; 

Meeting 

AGENCY: Federal Emergency 

Management Agency, Department of 

Homeland Security. 

ACTION: Notice of Open Federal 

Advisory Committee Meeting. 

SUMMARY: The Federal Emergency 

Management Agency (FEMA) Technical 

Mapping Advisory Council (TMAC) will 

hold a virtual public meeting on Friday, 

Oct. 27, 2023. The meeting will be open 

to the public via a Microsoft Teams 

Video Communications link. 

DATES: The TMAC will meet on Friday, 

Oct. 27, 2023, from 8 a.m. to 5 p.m. 

Eastern Standard Time (EST). Please 

note that the meeting will close early if 

the TMAC has completed its business. 

ADDRESSES: The meeting will be held 

virtually using the following Microsoft 

Teams Video Communications link 

(https://tinyurl.com/5cdwv54e). 

Members of the public who wish to 

attend the in-person or virtual meeting 

must register in advance by sending an 

email to FEMA-TMAC@fema.dhs.gov 

(Attn: Brian Koper) by 5 p.m. EST on 

Wednesday, Oct. 18, 2023. 

To facilitate public participation, 

members of the public are invited to 

provide written comments on the issues 

to be considered by the TMAC, as listed 

in the SUPPLEMENTARY INFORMATION

caption below. Associated meeting 

materials will be available upon request 

after Wednesday, Oct. 18, 2023. To 

receive a copy of any relevant materials, 

please send the request to: FEMATMAC@fema.dhs.gov (Attn: Brian 

Koper). Written comments to be 

considered by the committee at the time 

of the meeting must be submitted and 

received by Friday, Oct. 20, 2023, 5 p.m. 

EST, identified by Docket ID FEMA– 

2014–0022, and submitted by one of the 

following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Email: Address the email TO: 

FEMA-TMAC@fema.dhs.gov. Include 

the docket number in the subject line of 

the message. Include name and contact 

information in the body of the email. 

Instructions: All submissions received 

must include the words ‘‘Federal 

Emergency Management Agency’’ and 

the docket number for this action. 

Comments received will be posted 

without alteration at http://

www.regulations.gov, including any 

personal information provided. You 

may wish to review the Privacy & 

Security Notice via a link on the 

homepage of www.regulations.gov. 

Docket: For docket access to read 

background documents or comments 

received by the TMAC, go to http://

www.regulations.gov and search for the 

Docket ID FEMA–2014–0022. 

A public comment period will be held 

on Friday, Oct. 27, 2023, from noon to 

12:30 p.m. EST. The public comment 

period will not exceed 30 minutes. 

Please note that the public comment 

period may end before the time 

indicated, following the last call for 

comments. Contact the individual listed 

below to register as a speaker by 

Wednesday, Oct. 18, 2023, 5 p.m. EST. 

Please be prepared to submit a written 

version of your public comment. 

FEMA is committed to ensuring all 

participants have equal access 

regardless of disability status. If you 

require reasonable accommodation due 

to a disability to fully participate, please 

contact the individual listed in the FOR

FURTHER INFORMATION CONTACT caption 

as soon as possible. 

FOR FURTHER INFORMATION CONTACT: 

Brian Koper, Designated Federal Officer 

for the TMAC, FEMA, 400 C St. SW, 

Washington, DC 20472, 202–646–3085, 

brian.koper@fema.dhs.gov. The TMAC 

website is: https://www.fema.gov/floodmaps/guidance-partners/technicalmapping-advisory-council. 

SUPPLEMENTARY INFORMATION: Notice of 

this meeting is given under the Federal 

Advisory Committee Act, Public Law 

117–286, 5 U.S.C. ch. 10. 

In accordance with the Biggert-Waters 

Flood Insurance Reform Act of 2012, the 

TMAC makes recommendations to the 

FEMA Administrator on: (1) how to 

improve, in a cost-effective manner, the 

(a) accuracy, general quality, ease of use, 

and distribution and dissemination of 

flood insurance rate maps and risk data; 

and (b) performance metrics and 

milestones required to effectively and 

efficiently map flood risk areas in the 

United States; (2) mapping standards 


lotter on DSK11XQN23PROD with NOTICES1